Collaborative-care Rehabilitation After Dysvascular Amputation

July 18, 2019 updated by: University of Colorado, Denver

Collaborative-care Rehabilitation to Improve Functional Outcomes After Dysvascular Amputation

The objective of this study is to examine the feasibility of using a collaborative-care, home-based rehabilitation program to improve functional outcomes for people recovering from lower limb amputation caused by vascular problems and/or diabetes complications. The primary hypothesis is that the rehabilitation program will result in greater improvements in performance-based and participant-reported measures of physical function, compared to standard of care after outpatient rehabilitation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

38

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • University of Colorado Anschutz Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Diabetes and/or Peripheral Artery Disease
  2. Unilateral transtibial amputation < 6 months prior to screening
  3. Household ambulation using definitive prosthesis prior to baseline testing
  4. Participation in physical rehabilitation at time of baseline testing
  5. Live within 45 minutes of a participating clinic

Exclusion Criteria:

  1. Require wheelchair for mobility (use prosthesis for transfers only)
  2. Ankle-level or above amputation on contralateral limb
  3. Traumatic or cancer-related amputation
  4. Uncontrolled heart condition
  5. Acute systemic infection
  6. Pregnancy
  7. Decisionally challenged
  8. Prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exercise, activity, and self-management
Exercise, Walking Program, and Health Self-Management Support. Participants will be visited at home once monthly and contacted by phone once weekly over 12 weeks to deliver the interventions.
Exercise will target muscle strength and joint mobility impairments and will be delivered over a 12 week period.
A walking program will be established with the goal of participants walking at least five days per week. Duration of program is 12 weeks.
Health self-management support will be delivered with weekly meetings between the researcher and participant over a 12-week period.
No Intervention: Home and phone visit
No intervention will be applied. Participants will be visited at home once monthly and contacted by phone once weekly over 12 weeks to monitor health status.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Timed Up-and-Go Test
Time Frame: Baseline, 12-weeks, and 24 weeks
Performance-based physical function test able to predict falls for people with lower limb amputation. The TUG test time is taken from rising from a chair, walking 3 meters, turning, walking back and sitting down. Continuous scale; higher time indicates lower physical function, higher likelihood of falls.
Baseline, 12-weeks, and 24 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Two-Minute Walk Test
Time Frame: Baseline, 12 weeks, and 24 weeks
Performance-based physical function test measures total number of meters walked in two minutes on a level walkway.
Baseline, 12 weeks, and 24 weeks
Five Meter Walk Test
Time Frame: Baseline, 12 weeks, and 24 weeks
Performance-based physical function test measures the time to walk 5 meters at the participant's "normal, everyday pace".
Baseline, 12 weeks, and 24 weeks
Prosthesis Evaluation Questionnaire - Mobility Section
Time Frame: Baseline, 12 weeks, and 24 weeks
Self-report physical function questionnaire measures capacity to perform a list of specific functional tasks (e.g., walking upstairs, getting in and out of a vehicle. Scores range from being unable or hardly able (0) to having no problems (4). An average score across the 12-item questionnaire was used in the analysis. Lower numbers indicate less difficulty.
Baseline, 12 weeks, and 24 weeks
Houghton Scale
Time Frame: Baseline, 12 weeks, and 24 weeks
Self-report physical function questionnaire. The outcome is the sum of scores from each item (min 0, max 12). A higher score indicates higher self-report of physical function with the prosthesis.
Baseline, 12 weeks, and 24 weeks
Patient-Specific Function Scale
Time Frame: Baseline, 12 weeks, and 24 weeks
Self-report physical function questionnaire. The outcome is the average score for up to five participant-identified activities on a scale from 0-10 (min 0, max 10). Higher score indicates greater ability to perform functional activities.
Baseline, 12 weeks, and 24 weeks
Physical Activity Step Counts
Time Frame: Baseline, 12 weeks, and 24 weeks
Instrumented physical activity measure, average step counts per day
Baseline, 12 weeks, and 24 weeks
Self-Efficacy in Managing Chronic Disease Questionnaire
Time Frame: Baseline, 12 weeks, and 24 weeks
Scale range is 1-10. The score for the scale is the mean of the six items, using a ten point scale. Higher number indicates higher self-efficacy.
Baseline, 12 weeks, and 24 weeks
World Health Organization Disability Assessment Scale
Time Frame: Baseline, 12 weeks, and 24 weeks
Scores ranging from 1 (no difficulty) to 5 (extreme difficulty/cannot do). Overall disability was calculated by summing the scores for the 12 items; higher scores indicated greater disability (score range: 12-60).
Baseline, 12 weeks, and 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 9, 2013

Primary Completion (Actual)

March 27, 2017

Study Completion (Actual)

June 29, 2017

Study Registration Dates

First Submitted

August 19, 2013

First Submitted That Met QC Criteria

August 21, 2013

First Posted (Estimate)

August 27, 2013

Study Record Updates

Last Update Posted (Actual)

August 14, 2019

Last Update Submitted That Met QC Criteria

July 18, 2019

Last Verified

July 1, 2019

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Complications

Clinical Trials on Exercise

Subscribe